Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Righi
P1.13-20 MET Protein Expression and Activation During Targeted Therapy in EGFR Mutated Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.09-21 Women With Synchronous or Metachronous Lung and Ovarian Cancers: A Multi-Institutional Report
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
P1.13-12 EGFR Therapy in ASCL1 Positive Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Lung Adenocarcinoma: Guiding EGFR-targeted Therapy and Beyond
Modern Pathology
Forensic Medicine
Pathology
Proteogenomic Systems Analysis Identifies Targeted Therapy Resistance Mechanisms in EGFR-mutated Lung Cancer
International Journal of Cancer
Cancer Research
Oncology
Risk Factors of Brain Metastasis During the Course of EGFR-TKIs Therapy for Patients With EGFR-mutated Advanced Lung Adenocarcinoma
Oncotarget
Oncology
ALK Fusion Protein Expression in Lung Adenocarcinoma and Its Correlation With EGFR Protein Expression
Madridge Journal of Oncogenesis
MET-EGFR Dimerization in Lung Adenocarcinoma Is Dependent on EGFR Mtations and Altered by MET Kinase Inhibition
PLoS ONE
Multidisciplinary
DNA Damage Repair Protein Expression and EGFR Gene Status in Lung Adenocarcinoma Patients
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
18f-Fluorodeoxyglucose Uptake Predicts MET Expression in Lung Adenocarcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Combination of Crizotinib and Osimertinib or Erlotinib Might Overcome MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutated Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
